Sir Dave Brailsford broke his protracted silence on Monday to deny any wrongdoing on the part of Bradley Wiggins and Team Sky over the Tour de France winner’s use of the Therapeutic Use Exemptions (TUEs). Confidential documents released from the World Anti-Doping Agency’s computer system showed Wiggins had received intramuscular injections of the powerful corticosteroid triamcinolone in the days leading up to three of cycling’s Grand Tours, the 2011 Tour de France, 2012 Tour de France which he won, and the 2013 Giro d’Italia. Sign up to our daily newsletter for up to date global news and features. There is no suggestion that Wiggins has committed any anti-doping offense but he has faced questions
LONDON — Three-time Tour de France winner Chris Froome says the anti-doping system is “open to abuse” by letting athletes take banned substances as medication. Froome, whose two officially approved “therapeutic use exemptions” in his career were revealed by hackers this month, writes on Twitter “I know that I have to not only abide by the rules but go above and beyond that to set a good example both morally and ethically.” Bradley Wiggins, another British Tour de France winner, has been criticized over TUEs. Hackers leaked that Wiggins got intramuscular injections of a strong corticosteroid days before three big races, including the 2012 Tour. When Wiggins won the 2012 Tour, Froome was runner-up.
Team Sky chief Dave Brailsford has insisted British cycling great Bradley Wiggins did nothing wrong in receiving a therapeutic use exemption (TUE) for otherwise banned drugs. Wiggins has been in the spotlight since leaked medical data showed the multiple Olympic champion had been granted a TUE by cycling authorities for the powerful corticosteroid triamcinolone, which he was permitted to take just days before the 2012 Tour de France, which he won, as well as the 2011 Tour and the 2013 Giro d'Italia. Wiggins said he needed the drug to help control his asthma.